Evidence map›Paper›PMID 22338096›Full record

ArticleDiabetes2012

Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.

Huating Li, Zhanguo Gao, Jin Zhang, Xin Ye, Aimin Xu, Jianping Ye, Weiping Jia

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 2 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Liver Brain Interactions: Focus on FGF21 a Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Huating LiDepartment of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China. wpjia@sjtu.edu.cn
Zhanguo Gao
Jin Zhang
Xin Ye
Aimin Xu
Jianping Ye
Weiping Jia
Pennington Biomedical Research Center · USShanghai Jiao Tong University · CNUniversity of Hong Kong · HK

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
THE ROLE OF PROTEIN MALNUTRITION ON CIRCADIAN PHYSIOLOGY OF C57BL/6J MOUSE DAMSP20RR021945 · NCRR · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI GETTYS, THOMAS W · 2006 to 2011
$9.5M
Mechanism of IKK in FFA-associated Insulin ResistanceR01DK068036 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI YE, JIANPING · 2004 to 2013
$2.7M
Regulation of Energy Expenditure by NF-kBR56DK068036 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI YE, JIANPING · 2009 to 2015
$296k
NCRR NIH HHS P20 RR021945NCRR NIH HHS P20-RR021945NIDDK NIH HHS 2P30-DK072476-06NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK068036NIDDK NIH HHS R01-DK068036-06NIDDK NIH HHS R56 DK068036
6 · The paper itself

Abstract

Fibroblast growth factor 21 (FGF21) stimulates fatty acid oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in the metabolic activity of sodium butyrate, a dietary histone deacetylase (HDAC) inhibitor. FGF21 expression was examined in serum and liver after injection of sodium butyrate into dietary obese C57BL/6J mice. The role of FGF21 was determined using antibody neutralization or knockout mice. FGF21 transcription was investigated in liver and HepG2 hepatocytes. Trichostatin A (TSA) was used in the control as an HDAC inhibitor. Butyrate was compared with bezafibrate and fenofibrate in the induction of FGF21 expression. Butyrate induced FGF21 in the serum, enhanced fatty acid oxidation in mice, and stimulated ketone body production in liver. The butyrate activity was significantly reduced by the FGF21 antibody or gene knockout. Butyrate induced FGF21 gene expression in liver and hepatocytes by inhibiting HDAC3, which suppresses peroxisome proliferator-activated receptor-α function. Butyrate enhanced bezafibrate activity in the induction of FGF21. TSA exhibited a similar set of activities to butyrate. FGF21 mediates the butyrate activity to increase fatty acid use and ketogenesis. Butyrate induces FGF21 transcription by inhibition of HDAC3.

Indexed as

AnimalsBezafibrateButyratesDietary FatsFibroblast Growth FactorsGene Expression RegulationHEK293 CellsHep G2 CellsHistone Deacetylase 3Histone DeacetylasesHumansHypolipidemic AgentsLiverMaleMiceMice, KnockoutBezafibrateButyratesDietary Fatsfibroblast growth factor 21Fibroblast Growth FactorsHistone Deacetylase 3Histone DeacetylasesHypolipidemic AgentsPPAR alphaRNA, Messenger

Identifiers

PMID22338096
PMCPMC3314370
OpenAlexW2146517905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.